Newsletter / Paid-only Variants of Concern & Variants of Interest: SARS-CoV-2 By Priti Patnaik / 4 May 2021
Newsletter / Paid-only Countries divided on ways to reform WHO emergency preparedness By Priti Patnaik / 30 Apr 2021
Newsletter / Paid-only COVAX counts on dose-sharing to counter vaccine crunch, vaccine diplomacy makes it worse By Priti Patnaik / 27 Apr 2021
Newsletter / Paid-only "A hole in the firewall": The WHO Foundation & WHO; "Green shoots" for TRIPS Waiver Talks? By Priti Patnaik / 23 Apr 2021
Newsletter / Paid-only India: The Quagmire for COVAX; Q&A: Hyo Yoon Kang on the financialization of intellectual property & COVID-19 By Priti Patnaik / 20 Apr 2021
Newsletter / Paid-only WHO & WTO converge on bilateral tech transfer for vaccines. What this means for the TRIPS Waiver By Priti Patnaik / 16 Apr 2021
Newsletter / Paid-only WHO’s "Bretton Woods Moment" Dimmed by Member States’ Reluctance To Pay Up More By Priti Patnaik / 9 Apr 2021
Newsletter / Paid-only Pathogens-Sharing & The Pandemic Treaty: The Commercial Link By Priti Patnaik / 2 Apr 2021
Newsletter / Members-only Examining the motivations for a pandemic treaty By Priti Patnaik / 31 Mar 2021
Newsletter / Paid-only Views from a vaccine manufacturer: Q&A - Abdul Muktadir, Incepta Pharmaceuticals; Pandemic Treaty Action By Priti Patnaik / 30 Mar 2021
